ASSERTIO THERAPEUTICS, INC. Selling Expense
ASSERTIO THERAPEUTICS, INC. reported Selling Expense of $0 for the 3-month period ending 2012-03-31, per its 10-Q filed 2012-05-08.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SellingExpense · last filed 2014-03-17
- ASSERTIO THERAPEUTICS, INC. selling expense for the quarter ending 2012-03-31 was $0.00, a 100.00% decline year-over-year.
- ASSERTIO THERAPEUTICS, INC. selling expense for the quarter ending 2011-12-31 was $0.00, a 100.00% decline year-over-year.
- ASSERTIO THERAPEUTICS, INC. selling expense for the quarter ending 2011-09-30 was $6.02M, a 11.31% decline year-over-year.
- ASSERTIO THERAPEUTICS, INC. selling expense for the quarter ending 2011-06-30 was $11.05M, a 36.50% increase year-over-year.
- ASSERTIO THERAPEUTICS, INC. selling expense for fiscal 2011 was $27.34M, a 12.99% decline from fiscal 2010.
- ASSERTIO THERAPEUTICS, INC. selling expense for fiscal 2010 was $31.42M, a 33.19% increase from fiscal 2009.
- ASSERTIO THERAPEUTICS, INC. selling expense for fiscal 2009 was $23.59M.
| Period end | Selling Expense 3 month | Selling Expense 6 month | Selling Expense 9 month | Selling Expense 12 month |
|---|---|---|---|---|
| 2012-03-31 | $0.00 10-Q · filed 2012-05-08 | $0.00 derived: sum of 2 quarters · filed 2014-03-17 | $6.02M derived: sum of 3 quarters · filed 2014-03-17 | $17.08M derived: sum of 4 quarters · filed 2014-03-17 |
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | $6.02M derived: sum of 2 quarters · filed 2014-03-17 | $17.08M derived: sum of 3 quarters · filed 2014-03-17 | $27.34M 10-K · filed 2014-03-17 |
| 2011-09-30 | $6.02M 10-Q · filed 2012-11-05 | $17.08M derived: sum of 2 quarters · filed 2012-11-05 | $27.34M 10-Q · filed 2012-11-05 | $34.99M derived: sum of 4 quarters · filed 2013-02-22 |
| 2011-06-30 | $11.05M 10-Q/A · filed 2012-08-13 | $21.32M 10-Q/A · filed 2012-08-13 | $28.97M derived: sum of 3 quarters · filed 2013-02-22 | $35.76M derived: sum of 4 quarters · filed 2013-02-22 |
| 2011-03-31 | $10.26M 10-Q · filed 2012-05-08 | $17.91M derived: sum of 2 quarters · filed 2013-02-22 | $24.70M derived: sum of 3 quarters · filed 2013-02-22 | $32.80M derived: sum of 4 quarters · filed 2013-02-22 |
| 2010-12-31 | $7.65M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-22 | $14.44M derived: sum of 2 quarters · filed 2013-02-22 | $22.54M derived: sum of 3 quarters · filed 2013-02-22 | $31.42M 10-K · filed 2013-02-22 |
| 2010-09-30 | $6.79M 10-Q · filed 2011-11-07 | $14.89M derived: sum of 2 quarters · filed 2011-11-07 | $23.77M 10-Q · filed 2011-11-07 | |
| 2010-06-30 | $8.10M 10-Q · filed 2011-08-02 | $16.98M 10-Q · filed 2011-08-02 | ||
| 2009-12-31 | $23.59M 10-K · filed 2012-03-08 |